Philip M. Brown
General Counsel at Galderma Laboratories LP
Profile
Philip M.
Brown is currently the Senior Vice President-Medical & Regulatory Affairs at Galderma Laboratories LP.
Prior to this, he was the Vice President-Clinical Development at Encysive Pharmaceuticals, Inc. from 1998 to 2003, the Senior Vice President-Clinical Development at Lexicon Pharmaceuticals, Inc. from 2009 to 2010, and the Associate Vice President-Medical Affairs at Pharmaceutical Research Associates, Inc. from 1994 to 1998.
Brown received his undergraduate degree from Hendrix College, his graduate degree from The University of Texas at Austin, and his doctorate from Texas Tech University.
Philip M. Brown active positions
Companies | Position | Start |
---|---|---|
Galderma Laboratories LP
Galderma Laboratories LP Pharmaceuticals: MajorHealth Technology Galderma Laboratories LP develops and markets dermatology and prescription products. It also offers treatments for skin conditions such as acne, rosacea, atopic dermatitis, soriasis, melasma and sunspots. Galderma Laboratories was founded in 1961 and is headquartered in Fort Worth, TX. | General Counsel | - |
Former positions of Philip M. Brown
Companies | Position | End |
---|---|---|
LEXICON PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 2010-10-14 |
Encysive Pharmaceuticals, Inc.
Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Encysive Pharmaceuticals, Inc. discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases. The firm focuses its research and development programs on the treatment and prevention of interrelated diseases of the vascular endothelium, inflammatory cascade and vascular diseases. The company was founded by James T. Willerson in 1989 and is headquartered in Houston, TX. | Chief Tech/Sci/R&D Officer | 2003-03-31 |
Pharmaceutical Research Associates, Inc.
Pharmaceutical Research Associates, Inc. Miscellaneous Commercial ServicesCommercial Services Pharmaceutical Research Associates, Inc. engages in the provision of clinical research services. It focuses on therapeutic, global regulatory affairs, and pharmacovigilance and patient safety. The company was founded in 1982 and is headquartered in Raleigh, NC. | Corporate Officer/Principal | 1998-11-30 |
Training of Philip M. Brown
Hendrix College | Undergraduate Degree |
Texas Tech University | Doctorate Degree |
The University of Texas at Austin | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
LEXICON PHARMACEUTICALS, INC. | Health Technology |
Private companies | 3 |
---|---|
Encysive Pharmaceuticals, Inc.
Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Encysive Pharmaceuticals, Inc. discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases. The firm focuses its research and development programs on the treatment and prevention of interrelated diseases of the vascular endothelium, inflammatory cascade and vascular diseases. The company was founded by James T. Willerson in 1989 and is headquartered in Houston, TX. | Health Technology |
Pharmaceutical Research Associates, Inc.
Pharmaceutical Research Associates, Inc. Miscellaneous Commercial ServicesCommercial Services Pharmaceutical Research Associates, Inc. engages in the provision of clinical research services. It focuses on therapeutic, global regulatory affairs, and pharmacovigilance and patient safety. The company was founded in 1982 and is headquartered in Raleigh, NC. | Commercial Services |
Galderma Laboratories LP
Galderma Laboratories LP Pharmaceuticals: MajorHealth Technology Galderma Laboratories LP develops and markets dermatology and prescription products. It also offers treatments for skin conditions such as acne, rosacea, atopic dermatitis, soriasis, melasma and sunspots. Galderma Laboratories was founded in 1961 and is headquartered in Fort Worth, TX. | Health Technology |
- Stock Market
- Insiders
- Philip M. Brown